Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists

  • David Koes,

    Affiliation Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  • Kareem Khoury,

    Affiliation School of Pharmacy, University of Pittsburgh, Pittsburgh Pennsylvania, United States of America

  • Yijun Huang,

    Affiliation School of Pharmacy, University of Pittsburgh, Pittsburgh Pennsylvania, United States of America

  • Wei Wang,

    Affiliation School of Pharmacy, University of Pittsburgh, Pittsburgh Pennsylvania, United States of America

  • Michal Bista,

    Affiliation Max Planck Institute of Biochemistry, Martinsried, Germany

  • Grzegorz M. Popowicz,

    Affiliation Max Planck Institute of Biochemistry, Martinsried, Germany

  • Siglinde Wolf,

    Affiliation Max Planck Institute of Biochemistry, Martinsried, Germany

  • Tad A. Holak,

    Affiliation Max Planck Institute of Biochemistry, Martinsried, Germany

  • Alexander Dömling,

    Affiliations Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, School of Pharmacy, University of Pittsburgh, Pittsburgh Pennsylvania, United States of America

  • Carlos J. Camacho

    ccamacho@pitt.edu

    Affiliation Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists

  • David Koes, 
  • Kareem Khoury, 
  • Yijun Huang, 
  • Wei Wang, 
  • Michal Bista, 
  • Grzegorz M. Popowicz, 
  • Siglinde Wolf, 
  • Tad A. Holak, 
  • Alexander Dömling, 
  • Carlos J. Camacho
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.